Literature DB >> 19578790

Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis.

Nghi Phung1, Natasha Pera, Geoffrey Farrell, Isabelle Leclercq, Jing Yun Hou, Jacob George.   

Abstract

The mechanistic significance of oxidative stress to fibrogenesis in the methionine and choline-deficient (MCD) diet-induced model of steatohepatitis was evaluated by antioxidant intervention, using either vitamin E or L-2-oxothiazolidine-4-carboxylate (OTC), a cysteine precursor that promotes glutathione synthesis. Significant depletion of hepatic reduced glutathione (GSH) and elevation of thiobarbituric acid reactive substances (TBARS) occurred from week 3 in association with hepatic injury in mice fed the MCD diet. Hepatic stellate cell (HSC) activation and increased collagen alpha1(I) mRNA expression, together with morphologic fibrosis were evident from week 5. Vitamin E repleted GSH, reduced TBARS, steatosis, inflammation, HSC activation and collagen alpha1(I) mRNA expression, and ameliorated fibrosis. Vitamin E did not effect the expression of either profibrogenic cytokines (transforming growth factor-beta 1, connective tissue growth factor) or matrix remodeling enzymes (tissue inhibitor of metalloproteinase-1 and -2, matrix metalloproteinase-2 and -13). Despite repletion of hepatic GSH in OTC-supplemented mice, the initial benefit in the reduction of hepatic TBARS and inhibition of collagen alpha1(I) mRNA expression at week 5, failed to protect these mice from hepatic injury or fibrosis at later time points. Oxidative stress or products of lipid peroxidation mediate HSC activation and collagen gene expression directly in the MCD model of steatohepatitis. Vitamin E but not glutathione augmentation can interrupt this pathogenic process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19578790     DOI: 10.3892/ijmm_00000220

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  29 in total

1.  Association between vitamin E and non-alcoholic steatohepatitis: a meta-analysis.

Authors:  Renfan Xu; Anyu Tao; Shasha Zhang; Youbin Deng; Guangzhi Chen
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  Antifibrotic therapies in the liver.

Authors:  W Z Mehal; D Schuppan
Journal:  Semin Liver Dis       Date:  2015-05-14       Impact factor: 6.115

3.  Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.

Authors:  Qiang Ou; Yuanyuan Weng; Siwei Wang; Yajuan Zhao; Feng Zhang; Jianhua Zhou; Xiaolin Wu
Journal:  Dig Dis Sci       Date:  2018-09-06       Impact factor: 3.199

Review 4.  New insights from rodent models of fatty liver disease.

Authors:  Jacquelyn J Maher
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

5.  Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.

Authors:  Jamil A Haque; Ryan S McMahan; Jean S Campbell; Masami Shimizu-Albergine; Angela M Wilson; Dianne Botta; Theo K Bammler; Richard P Beyer; Thomas J Montine; Matthew M Yeh; Terrance J Kavanagh; Nelson Fausto
Journal:  Lab Invest       Date:  2010-06-14       Impact factor: 5.662

Review 6.  Animal models of nonalcoholic fatty liver disease.

Authors:  Lionel Hebbard; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-30       Impact factor: 46.802

7.  The effects of α-lipoic acid on liver oxidative stress and free fatty acid composition in methionine-choline deficient diet-induced NAFLD.

Authors:  Milena N Stanković; Dušan Mladenović; Milica Ninković; Ivana Ethuričić; Slađana Sobajić; Bojan Jorgačević; Silvio de Luka; Rada Jesic Vukicevic; Tatjana S Radosavljević
Journal:  J Med Food       Date:  2013-12-10       Impact factor: 2.786

8.  Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment.

Authors:  Judit Marsillach; Gerard Aragonès; Bharti Mackness; Michael Mackness; Anna Rull; Raúl Beltrán-Debón; Juan Pedro-Botet; Carlos Alonso-Villaverde; Jorge Joven; Jordi Camps
Journal:  Lipids Health Dis       Date:  2010-05-14       Impact factor: 3.876

Review 9.  Vitamin E and nonalcoholic fatty liver disease.

Authors:  Tommy Pacana; Arun J Sanyal
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-11       Impact factor: 4.294

10.  Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.

Authors:  Joel E Lavine; Jeffrey B Schwimmer; Jean P Molleston; Ann O Scheimann; Karen F Murray; Stephanie H Abrams; Philip Rosenthal; Arun J Sanyal; Patricia R Robuck; Elizabeth M Brunt; Aynur Unalp; James Tonascia
Journal:  Contemp Clin Trials       Date:  2009-09-15       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.